Analysis on Antihypertensive Drugs Used in 34 Hospitals of Wuhan City during 2013 and 2015
10.3969/j.issn.1008-049X.2018.03.020
- VernacularTitle:2013～2015年武汉市34家医院抗高血压药使用情况分析
- Author:
Anhua WEI
1
;
Chengliang ZHANG
;
Dong LIU
Author Information
1. 华中科技大学同济医学院附属同济医院药学部 武汉430030
- Keywords:
Antihypertensive drugs;
Defined daily dose;
DDDs;
Defined daily cost
- From:
China Pharmacist
2018;21(3):451-454
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the current situation and trend of the utilization of antihypertensive drugs in Wuhan city. Methods:The utilization data including varieties,consumption sum and DDDs of antihypertensive drugs in 34 hospitals in Wuhan city from 2013 to 2015 were analyzed.Results:The annual consumption sum of antihypertensive drugs increased year by year,and the val-ue was 20 896.67,23 527.19 and 24 033.44 million yuan, respectively. The calcium-channel blockers (CCB), angiotensin Ⅱ re-ceptor antagonist (ARB),adrenergic receptor blockers and angiotensin converting enzyme inhibitors (ACEIs) ranked the top four in consumption sum of antihypertensive drugs. Their constituent ratio was not changed during 2013 and 2015. The consumption amount and DDDs of new compound preparations increased. Top two drugs in terms of consumption amount and DDDs were amlodipine and le-vamlodipine. Conclusion:CCB,ARB,ACEI,adrenergic receptor blockers and diuretics occupy the predominant places among all the antihypertensive drugs in Wuhan city,which is accordance with the current treatment guideline of antihypertensive drugs.
